ArticleNature medicine2025
Author Correction: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial.
Yago Nieto et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it